Janssen Vaccines
| Company type | Subsidiary |
|---|---|
| Industry | Biotechnology |
| Founded | 2000 |
| Headquarters | Archimedesweg 4, Leiden , Netherlands |
Key people | Ronald Brus (CEO), Jan Pieter Oosterveld (Chairman of the supervisory board) |
| Products | Vaccines and antibodies |
| Parent | Johnson & Johnson |
| Website | www |
Janssen Vaccines, formerly Crucell, is a biotechnology company specializing in vaccines and biopharmaceutical technologies. It was formed when Johnson & Johnson acquired the Dutch biotech company Crucell based in Leiden and placed it in their pharmaceutical division.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.